Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids

Drug Metabolism and Disposition

Volumn 26, Issue 10, 1998, Pages 989-992

  Zhai, Suoping ^b   Dai, Renke ^b   Friedman, Fred K ^b   Vestal, Robert E ^a  

^a Boise VA Medical Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYFLAVONE; 3,7 DIHYDROXYFLAVONE; 7 HYDROXYFLAVONE; COMPLEMENTARY DNA; CYTOCHROME P450 INHIBITOR; CYTOCHROME P450 ISOENZYME; ETHOXYRESORUFIN; ETHOXYRESORUFIN DEETHYLASE; FLAVONE; FLAVONOID; GALANGIN; METHOXYRESORUFIN; METHOXYRESORUFIN O DEMETHYLASE; PHENACETIN O DEETHYLASE; PRIMULETIN; RESORUFIN; RESORUFIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL;

CELL LINE; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; FLAVONOIDS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031785065     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Block G, Patterson B and Subar A (1992) Fruits, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18:1-29.
2. Brosen K (1995) Drug interactions and the cytochrome P450 system: the role of cytochrome P4501A2. Clin Pharmacokinel 29:20-25.
3. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T and Mayer RT (1985) Ethoxy-, pentoxy-, and benzyloxyphenoxazones and homologues. Biochem Pharmacol 34:3337-3345.
4. Dai R, Zhai S, Wei X, Pincus MR, Vestal RE and Friedman FK (1998) Inhibition of human cytochrome P450 1A2 by flavones: a molecular modeling study. J Protein Chem, in press.
5. Dechner EE, Roberto J, Wang G and Newmark HL (1991) Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasm. Carcinogenesis (Lond) 7:1193-1196.
6. Digiovanni J (1990) Inhibition of chemical carcinogenesis, in Chemical Carcinogenesis and Mutagenesis (Cooper CS and Grover PL eds) pp 159-253, Springer-Verlag, Berlin.
7. Friedman FK, West D, Sugimura T and Gelboin HV (1985) Flavone modulators of rat hepatic aryl hydrocarbon hydroxylase. Pharmacology 31:203-207.
8. Fuhr U, Klittich K and Staib AH (1993) Inhibitory effect of grapefruit juice and the active component, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol 35:431-436.
9. Gonzalez FJ (1989) The molecular biology of cytochrome P450s. Pharmacol Rev 40:243-288.
10. Guengerich FP (1988) Roles of cytochrome P450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res 48:2946-2954.
11. Guengerich FP (1990) Characterization of human cytochrome P450 enzyme in carcinogen metabolism. Asian Pac J Pharmacol 5:327-345.
12. Guengerich FP (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes. Chem Res Toxicol 4:391-407.
13. Havsteen B (1983) Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32:1141-1148.
14. Heo MY, Jae LH, Jung SS and Au WW (1996) Anticlastogenic effect of galangin against mitomycin C-induced micronuclei in reticulocytes of mice. Mutat Res 360:37-41.
15. Heo MY, Yu KS, Kim KH, Kim HP and Au WW (1992) Anticlastogenic effect of flavonoids against mutagen-induced micronuclei in mice. Mutat Res 284:243-249.
16. Hertog MGL, Hollman PCH, Katan MB and Kromhout D (1993) Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer 20:21-29.
17. Kawajiri K, Nakachi K, Imai K, Watanabe J and Hayashi S (1993) The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol 14:77-87.
18. Kuhnau J (1976) A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 24:117-191.
19. Lasker JM, Huang MT and Conney AH (1984) In vitro and in vivo activation of oxidative drug metabolism by flavonoids. J Pharmacol Exp Ther 229:162-170.
20. McLemore TL, Adelberg S, Liu MC and Hines RN (1990) Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst 82:1333-1339.
21. Mukhtar H, Das M, Khan WA and Bik DP (1988) Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethybenz(a)anthracene-, benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. Cancer Res 48:2361-2365.
22. Obermeier MT, White RE and Yang CS (1995) Effects of bioflavonoids on hepatic P450 activities. Xenobiotica 25:575-584.
23. Pastrakuljic A, Tang BK, Roberts EA and Kalow W (1997) Distinction of CYP1A1 and CYP1A2 activity by selective inhibition using fluvoxamine and isosafrole. Biochem Pharmacol 53: 531-538.
24. Pierpoint WS (1986) Flavonoids in the human diet, in Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structure-Activity Relationships (Cody V, Middleton E Jr and Harborne JB ed) pp 125-140, Alan R. Liss, Inc., New York.
25. Rendic S and Di Carlo FJ (1997) Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev 29:413-580.
26. Sabatier S, Amiot MJ, Tacchini M and Aubert S (1992) Identification of flavonoids in sunflower honey. J Food Sci (Wash DC) 3:773-774.
27. Siess MH, Bon AM, Suschetet M and Rat P (1990) Inhibition of ethoxyresorufin deethylase activity by natural flavonoids in human and rat liver microsomes. Food Addit Contam 7:S178-S181.
28. Siess MH, Leclerc J, Canivenc-Lavier MC, Rat P and Suschetet M (1995) Heterogeneous effects of natural flavonoids on monooxygenase activities in human and rat liver microsomes. Toxicol Appl Pharmacol 130:73-78.
29. Siess MH, Pennec A and Gaydou E (1989) Inhibition of ethoxy-and pentoxy-resorufin dealky-lases of rat liver by flavonols: structure-activity relationship. Eur J Drug Metab Pharmacokinet 14:235-239.
30. Sivaraman L, Leatham MP, Yee J, Wilkens LR and Marchand LL (1994) CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res 54:3692-3695.
31. Smith TJ, Guo Z, Guengerich FP and Yang CS (1996) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Carcinogenesis (Lond) 17:809-813.
32. Trela BA and Carlson GP (1987) Effect of flavonone on mixed-function oxidase and conjugation reactions in rats. Xenobiotica 17:11-16.
33. Tsyrlov IB, Mikhailenko VM and Gelboin HV (1994) Isozyme-and species-specific susceptibility of cUNA-expressed CYP1A P450s to different flavonoids. Biochim Biophys Acta 1205:325-335.
34. Verma AK, Johnson JA, Gould MN and Tanner MA (1988) Inhibition of 7,12-dimethylben-z(a)anthracene-and W-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res 48:5754-5788.
35. Wattenberg LW (1992) Inhibition of carcinogenesis by minor dietary compounds. Cancer Res 52:2085-2091.
36. Wei H, Tye L, Bresnick E and Birt DF (1990) Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 50:499-502.